William H Rounds1, Edward A Salinas2, Tom B Wilks3, Mikhail K Levin2, Ann J Ligocki1, Carolina Ionete4, Carlos A Pardo5, Steven Vernino1, Benjamin M Greenberg1, Douglas W Bigwood3, Eric M Eastman3, Lindsay G Cowell2, Nancy L Monson6. 1. Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX, USA. 2. Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX, USA. 3. DioGenix Inc., Bethesda, MD, USA. 4. Department of Neurology, UMass Memorial Medical Center, Worcester, MA, USA. 5. Department of Neurology and Neurosurgery, John Hopkins University, Baltimore, MD, USA. 6. Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX, USA; Department of Immunology, UT Southwestern Medical Center, Dallas, TX, USA. Electronic address: nancy.monson@utsouthwestern.edu.
Abstract
BACKGROUND: We have previously demonstrated that cerebrospinal fluid-derived B cells from early relapsing-remitting multiple sclerosis (RRMS) patients that express a VH4 gene accumulate specific replacement mutations. These mutations can be quantified as a score that identifies such patients as having or likely to convert to RRMS. Furthermore, we showed that next generation sequencing is an efficient method for obtaining the sequencing information required by this mutation scoring tool, originally developed using the less clinically viable single-cell Sanger sequencing. OBJECTIVE: To determine the accuracy of MSPrecise, the diagnostic test that identifies the presence of the RRMS-enriched mutation pattern from patient cerebrospinal fluid B cells. METHODS: Cerebrospinal fluid cell pellets were obtained from RRMS and other neurological disease (OND) patient cohorts. VH4 gene segments were amplified, sequenced by next generation sequencing and analyzed for mutation score. RESULTS: The diagnostic test showed a sensitivity of 75% on the RRMS cohort and a specificity of 88% on the OND cohort. The accuracy of the test in identifying RRMS patients or patients that will develop RRMS is 84%. CONCLUSION: MSPrecise exhibits good performance in identifying patients with RRMS irrespective of time with RRMS.
BACKGROUND: We have previously demonstrated that cerebrospinal fluid-derived B cells from early relapsing-remitting multiple sclerosis (RRMS) patients that express a VH4 gene accumulate specific replacement mutations. These mutations can be quantified as a score that identifies such patients as having or likely to convert to RRMS. Furthermore, we showed that next generation sequencing is an efficient method for obtaining the sequencing information required by this mutation scoring tool, originally developed using the less clinically viable single-cell Sanger sequencing. OBJECTIVE: To determine the accuracy of MSPrecise, the diagnostic test that identifies the presence of the RRMS-enriched mutation pattern from patient cerebrospinal fluid B cells. METHODS: Cerebrospinal fluid cell pellets were obtained from RRMS and other neurological disease (OND) patient cohorts. VH4 gene segments were amplified, sequenced by next generation sequencing and analyzed for mutation score. RESULTS: The diagnostic test showed a sensitivity of 75% on the RRMS cohort and a specificity of 88% on the OND cohort. The accuracy of the test in identifying RRMS patients or patients that will develop RRMS is 84%. CONCLUSION: MSPrecise exhibits good performance in identifying patients with RRMS irrespective of time with RRMS.
Authors: Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden Journal: J Immunol Date: 2003-09-01 Impact factor: 5.422
Authors: Jeffrey L Bennett; Kurt Haubold; Alanna M Ritchie; Sydni J Edwards; Mark Burgoon; Andrew J Shearer; Donald H Gilden; Gregory P Owens Journal: J Neuroimmunol Date: 2008-06-10 Impact factor: 3.478
Authors: M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning Journal: J Neurol Neurosurg Psychiatry Date: 1994-08 Impact factor: 10.154
Authors: Elizabeth M Cameron; Sade Spencer; Jonathan Lazarini; Christopher T Harp; E Sally Ward; Mark Burgoon; Gregory P Owens; Michael K Racke; Jeffrey L Bennett; Elliot M Frohman; Nancy L Monson Journal: J Neuroimmunol Date: 2009-07-24 Impact factor: 3.478
Authors: Scott D Boyd; Eleanor L Marshall; Jason D Merker; Jay M Maniar; Lyndon N Zhang; Bita Sahaf; Carol D Jones; Birgitte B Simen; Bozena Hanczaruk; Khoa D Nguyen; Kari C Nadeau; Michael Egholm; David B Miklos; James L Zehnder; Andrew Z Fire Journal: Sci Transl Med Date: 2009-12-23 Impact factor: 17.956
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Jacqueline R Rivas; Sara J Ireland; Rati Chkheidze; William H Rounds; Joseph Lim; Jordan Johnson; Denise M O Ramirez; Ann J Ligocki; Ding Chen; Alyssa A Guzman; Mark Woodhall; Patrick C Wilson; Eric Meffre; Charles White; Benjamin M Greenberg; Patrick Waters; Lindsay G Cowell; Ann M Stowe; Nancy L Monson Journal: Acta Neuropathol Date: 2016-10-11 Impact factor: 17.088
Authors: Tobias V Lanz; R Camille Brewer; Peggy P Ho; Jae-Seung Moon; Kevin M Jude; Daniel Fernandez; Ricardo A Fernandes; Alejandro M Gomez; Gabriel-Stefan Nadj; Christopher M Bartley; Ryan D Schubert; Isobel A Hawes; Sara E Vazquez; Manasi Iyer; J Bradley Zuchero; Bianca Teegen; Jeffrey E Dunn; Christopher B Lock; Lucas B Kipp; Victoria C Cotham; Beatrix M Ueberheide; Blake T Aftab; Mark S Anderson; Joseph L DeRisi; Michael R Wilson; Rachael J M Bashford-Rogers; Michael Platten; K Christopher Garcia; Lawrence Steinman; William H Robinson Journal: Nature Date: 2022-01-24 Impact factor: 69.504
Authors: Ann J Ligocki; Jacqueline R Rivas; William H Rounds; Alyssa A Guzman; Min Li; Melania Spadaro; Lauren Lahey; Ding Chen; Paul M Henson; Donna Graves; Benjamin M Greenberg; Elliot M Frohman; E Sally Ward; William Robinson; Edgar Meinl; Charles L White; Ann M Stowe; Nancy L Monson Journal: ASN Neuro Date: 2015-10-21 Impact factor: 4.146
Authors: Tina Khorshid Ahmad; Ting Zhou; Khaled AlTaweel; Claudia Cortes; Ryan Lillico; Ted Martin Lakowski; Kiana Gozda; Michael Peter Namaka Journal: Int J Mol Sci Date: 2017-06-12 Impact factor: 5.923
Authors: Jared Ostmeyer; Scott Christley; William H Rounds; Inimary Toby; Benjamin M Greenberg; Nancy L Monson; Lindsay G Cowell Journal: BMC Bioinformatics Date: 2017-09-07 Impact factor: 3.169
Authors: Scott Christley; Mikhail K Levin; Inimary T Toby; John M Fonner; Nancy L Monson; William H Rounds; Florian Rubelt; Walter Scarborough; Richard H Scheuermann; Lindsay G Cowell Journal: BMC Bioinformatics Date: 2017-10-11 Impact factor: 3.169
Authors: Scott Christley; Walter Scarborough; Eddie Salinas; William H Rounds; Inimary T Toby; John M Fonner; Mikhail K Levin; Min Kim; Stephen A Mock; Christopher Jordan; Jared Ostmeyer; Adam Buntzman; Florian Rubelt; Marco L Davila; Nancy L Monson; Richard H Scheuermann; Lindsay G Cowell Journal: Front Immunol Date: 2018-05-08 Impact factor: 7.561